J&J: BofA Global Research raises price objective to $282 from $278
JNJ•BofA Global Research raised its price objective for J&J to $282 from $278.
Related News
Vera Therapeutics price objective cut to $60 from $66
VERA•
Bristol-Myers Squibb Company: BofA Global Research cuts price objective to $66 from $71
BMY•
French and Italian debt risk premiums set for weekly decline
TLT•
Banco Bradesco director Rubens Aguiar Alvarez reports BRL 31.26 million common-share purchase
BBD•
South Bow Corporation: Barclays cuts to underweight from equal-weight; cuts target price to $33 from $35
SOBO•